Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 11, 2015 - Issue 7
Submit an article Journal homepage
1,430
Views
14
CrossRef citations to date
0
Altmetric
Commentary

Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma

Katherine A MurphyDepartment of Urology; University of Minnesota; Minneapolis, MN, USA
,
Britnie R JamesDepartment of Urology; University of Minnesota; Minneapolis, MN, USA
,
Yue GuanDepartment of Medical Microbiology Immunology and Cell Biology; Southern Illinois University School of Medicine; Springfield, IL, USA
,
Donald S TorryDepartment of Medical Microbiology Immunology and Cell Biology; Southern Illinois University School of Medicine; Springfield, IL, USA;Simmons Cancer Institute; Southern Illinois University School of Medicine; Springfield, IL, USA
,
Andrew WilberDepartment of Medical Microbiology Immunology and Cell Biology; Southern Illinois University School of Medicine; Springfield, IL, USA;Simmons Cancer Institute; Southern Illinois University School of Medicine; Springfield, IL, USA
&
Thomas S GriffithDepartment of Urology; University of Minnesota; Minneapolis, MN, USA;Microbiology, Immunology, and Cancer Biology Graduate Program; University of Minnesota; Minneapolis, MN, USA;Center for Immunology; University of Minnesota; Minneapolis, MN, USA;Masonic Cancer Center; University of Minnesota; Minneapolis, MN, USACorrespondence[email protected]
Pages 1612-1620 | Received 13 Mar 2015, Accepted 26 Mar 2015, Published online: 06 Jul 2015

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vincent Chau & Marijo Bilusic. (2020) Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date. Cancer Management and Research 12, pages 7321-7330.
Read now

Articles from other publishers (13)

Nguyen Xuong Duong, Minh‐Khang Le, Tetsuo Kondo & Takahiko Mitsui. (2022) Heterogeneity of Hippo signalling activity in different histopathologic subtypes of renal cell carcinoma. Journal of Cellular and Molecular Medicine 27:1, pages 66-75.
Crossref
Lamyae El Khalki, Hassan Ait Mouse, Abdeslam Jaafari, Moulay Mustapha Ennaji & Abdelmajid Zyad. 2023. Immunological Implications and Molecular Diagnostics of Genitourinary Cancer. Immunological Implications and Molecular Diagnostics of Genitourinary Cancer 389 409 .
Chen Yang, Tian Yu & Qin Lin. (2022) A signature based on chromatin regulation and tumor microenvironment infiltration in clear cell renal cell carcinoma. Epigenomics 14:17, pages 995-1013.
Crossref
Georgia Sofia Karachaliou, Nathan Hirshman & Tian Zhang. 2022. Urologic Oncology. Urologic Oncology 299 312 .
Guangyao Li, Xiyi Wei, Shifeng Su, Shangqian Wang, Wei Wang, Yichun Wang, Xianghu Meng, Jiadong Xia, Ninghong Song & Chao Qin. (2021) Identification of an independent immune-genes prognostic index for renal cell carcinoma. BMC Cancer 21:1.
Crossref
Deepika Singh. (2021) Current updates and future perspectives on the management of renal cell carcinoma. Life Sciences 264, pages 118632.
Crossref
Hao Cui, Hongjian Shan, Michael Zhe Miao, Zhiguo Jiang, Yuanyuan Meng, Ran Chen, Longzhen Zhang & Yong Liu. (2020) Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma. Scientific Reports 10:1.
Crossref
Ana Marisa Chudzinski-Tavassi, Kátia Luciano Pereira Morais, Jean Gabriel de Souza & Roger Chammas. 2020. Evolving Trends in Kidney Cancer. Evolving Trends in Kidney Cancer.
Yue Guan, Christopher B. Chambers, Taylor Tabatabai, Ha Hatley, Kristin R. Delfino, Kathy Robinson, Shaheen R. Alanee, Sophia Ran, Donald S. Torry & Andrew Wilber. (2020) Renal cell tumors convert natural killer cells to a proangiogenic phenotype. Oncotarget 11:26, pages 2571-2585.
Crossref
Iñigo Terrén, Ane Orrantia, Idoia Mikelez-Alonso, Joana Vitallé, Olatz Zenarruzabeitia & Francisco Borrego. (2020) NK Cell-Based Immunotherapy in Renal Cell Carcinoma. Cancers 12:2, pages 316.
Crossref
Giuseppe Badalamenti, Daniele Fanale, Lorena Incorvaia, Nadia Barraco, Angela Listì, Rossella Maragliano, Bruno Vincenzi, Valentina Calò, Juan Lucio Iovanna, Viviana Bazan & Antonio Russo. (2019) Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?. Cellular Immunology 343, pages 103753.
Crossref
Bryden Considine & Michael E. Hurwitz. (2019) Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma. Current Oncology Reports 21:4.
Crossref
Manny D. Bacolod, Francis Barany, Karsten Pilones, Paul B. Fisher & Romulo J. de Castro. 2019. 107 143 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.